Partex is a large AI-powered drug asset management company. It possesses a massive data ocean of public and proprietary biomedical information, enabling AI-driven drug discovery and development. Its platform supports decision-making, in-vitro validation, and medicinal chemistry, accelerating the process and reducing time to market. Partex boasts a significant portfolio of partnered and in-house drug assets, numerous patents, and a substantial global customer base.

Innoplexus, based in Pune, India, specializes in AI-driven solutions for the life sciences and healthcare sectors. Their offerings include advanced analytics platforms, data-driven insights, and AI-powered applications tailored to pharmaceuticals, biotechnology, and healthcare organizations. Innoplexus aims to enhance decision-making processes, accelerate drug discovery, optimize clinical trials, and improve patient outcomes through innovative data-driven approaches.

Assay.Works is a contract research organization (CRO) specializing in assay development and high-throughput screening (HTS) for drug discovery. Founded by experienced scientists from Amgen, they offer services ranging from assay development and HTS campaigns to hit identification and lead optimization, using automated systems and diverse readout capabilities. They work with various compound libraries and support clients across the drug discovery process, from early-stage to lead optimization.